Document is current
Any future updates will be listed below
-
Authors
Shcherbakov, Ilias https://orcid.org/0000-0002-9450-2153
Bryleva, Kateryna https://orcid.org/0000-0002-8903-4922
Strawbridge, Rebecca https://orcid.org/0000-0002-2984-1124
Nikolajeva, Milena https://orcid.org/0000-0002-5366-1879
Matkovska, Nataliya
Kravec, Vladimir
Ougrin, Dennis https://orcid.org/0000-0003-1995-5408
Young, Allan H. https://orcid.org/0000-0003-2291-6952
-
Funding
Funding for this research was provided by:
National Academy of Sciences of Ukraine (#0119U100727)
Barts Charity (MRC&U0042)
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 6 March 2025
First Online: 2 July 2025
Declarations
:
: In the past 3 years, R.S. declares honoraria from Janssen; A.H.Y. has received honoraria for attending advisory boards and presenting lectures for Allergan, Astra Zeneca, Bionomics, COMPASS, Eli Lilly, Janssen, LivaNova, Lundbeck, Servier, Sumitomo Dainippon Pharma and Sunovion, and has received consulting fees from Johnson & Johnson and LivaNova. All other authors declare that they have no conflicts of interest.
